Treatment for leukemia in adults depends mainly on the type of leukemia, its genetic features, and the person’s overall health. Acute leukemias usually need prompt, intensive treatment with chemotherapy, targeted drugs or immunotherapy, sometimes followed by a stem cell transplant. Chronic leukemias are often controlled with daily tablets or, in early slow-growing cases, careful monitoring before any treatment starts.
As a hematologist who looks after adults with blood disorders, I find that patients and caregivers cope far better once they understand the overall plan. This guide explains the main approaches and what each involves.
What Leukemia Is and Why Type Matters
Leukemia is a cancer of the blood-forming cells in the bone marrow. Abnormal cells, usually immature white blood cells, multiply and crowd out healthy blood production. This leads to anemia, infections and bleeding, along with symptoms such as fatigue, fevers and pain in the bones.
Leukemias are grouped by speed (acute or chronic) and by cell line (myeloid or lymphoid). Treatment is chosen only after diagnosing leukemia precisely, using blood tests, a bone marrow biopsy, flow cytometry and genetic testing.
| Type | Typical first approach in adults | Treatment goal |
|---|---|---|
| Acute myeloid leukemia (AML) | Intensive chemotherapy, or lower-intensity therapy plus targeted drugs for less fit patients | Remission, then prevent relapse; cure where possible |
| Acute lymphoblastic leukemia (ALL) | Multi-phase chemotherapy, often with targeted drugs or immunotherapy | Cure |
| Chronic myeloid leukemia (CML) | Daily tyrosine kinase inhibitor tablets | Deep, long-term control |
| Chronic lymphocytic leukemia (CLL) | Watch and wait if early; targeted tablets or antibody combinations when treatment is needed | Long-term control and good quality of life |
Main Treatment Options
Chemotherapy
Chemotherapy uses drugs that kill rapidly dividing cells. For acute leukemia it is given in phases: induction to achieve remission, consolidation to destroy remaining leukemia cells, and, for ALL, a longer maintenance phase. Induction for acute leukemia usually means several weeks in hospital while blood counts recover.
Targeted Therapy
Targeted drugs block specific abnormalities in leukemia cells. The best-known example is the use of tyrosine kinase inhibitors (TKIs) in CML, which block the BCR-ABL protein produced by the Philadelphia chromosome. Many people with CML take a daily tablet and live near-normal lives. Our article on diagnosing chronic myeloid leukemia covers this condition in more detail. Other targeted drugs act on FLT3 or IDH mutations in AML, and on BTK or BCL-2 in CLL.
Immunotherapy
Immunotherapy helps the immune system attack leukemia. Options include monoclonal antibodies, bispecific antibodies that link T cells to leukemia cells, and CAR T-cell therapy, in which a patient’s own T cells are engineered to target leukemia. CAR T-cell therapy is used mainly for relapsed or resistant B-cell ALL.
Stem Cell Transplantation
An allogeneic stem cell transplant replaces the patient’s marrow with healthy stem cells from a donor. It offers a chance of cure in higher-risk acute leukemia or after relapse, partly because the donor immune cells attack leftover leukemia. It carries significant risks, including infection and graft-versus-host disease, so it is considered carefully for each patient’s fitness and disease risk.
Choosing Between Intensive and Gentler Treatment
Not every adult is suited to the most intensive regimens. Age alone does not decide this; heart, lung, kidney and liver function, other illnesses and personal priorities all matter. For older or less fit adults with AML, lower-intensity treatment combined with targeted drugs can achieve good control with fewer hospital days. I always encourage patients to share what matters most to them, because that shapes the plan as much as the test results do.
Radiation Therapy
Radiation plays a smaller role. It may be used before a transplant, or to treat leukemia in the brain or a painful area.
For a broader overview of these approaches, see our guides to treatment options for leukemia and current and future leukemia treatment strategies.
Supportive Care During Treatment
Supportive care is as important as the anti-leukemia drugs. It includes:
- Blood and platelet transfusions while the marrow recovers; see our guide to treatment options for low platelets
- Infection prevention with antibiotics, antifungals and antivirals, plus rapid treatment of fever
- Anti-sickness medicines, mouth care and nutrition support
- Prevention of tumor lysis syndrome, a chemical imbalance when many leukemia cells die at once
- Fertility preservation discussions before treatment starts
- Psychological support for patients and caregivers
What to Expect as a Patient or Caregiver
Treatment is usually planned by a multidisciplinary team. The first weeks are often the most intense. Caregivers help by keeping a list of medicines, recording temperatures when asked, watching for warning signs, and coming to appointments to help remember information.
Response is measured with blood counts, repeat marrow tests and, increasingly, measurable residual disease (MRD) testing, which detects very small numbers of leukemia cells. MRD results help decide whether more treatment, such as a transplant, is needed.
| Stage of care | What typically happens |
|---|---|
| Diagnosis and planning | Marrow tests, genetic results, fitness assessment, treatment discussion |
| Active treatment | Chemotherapy cycles or daily targeted drugs; frequent blood tests |
| Response assessment | Repeat marrow and MRD testing |
| Follow-up | Regular clinic visits, monitoring for relapse and late effects |
When to Call Your Care Team
During treatment, a fever of 38°C (100.4°F) or higher is an emergency, because infection can progress quickly when white cells are low. Also call promptly for bleeding that will not stop, new bruising or rash, shortness of breath, confusion, severe diarrhea or vomiting, or being unable to eat or drink.
Frequently Asked Questions
Can leukemia in adults be cured?
Some types can. A proportion of adults with AML and ALL are cured with chemotherapy, targeted drugs and transplant, and CML is often controlled for many years with tablets. Outcomes depend strongly on the leukemia’s genetic features and the person’s age and fitness.
How long does leukemia treatment take?
Acute myeloid leukemia treatment often spans several months. Adult ALL treatment, including maintenance, commonly lasts two to three years. CML and CLL treatment may be continuous or given for a fixed period, depending on the drug.
Is a stem cell transplant always needed?
No. It is recommended when the risk of relapse is high or leukemia has returned, and when the person is fit enough. Many patients never need one.
Can I work during leukemia treatment?
It depends on the treatment. Many people on daily tablets for CML or CLL continue working, while intensive chemotherapy for acute leukemia usually requires several months away from work.
What can caregivers do to help?
Caregivers can help with transport, meals and medicines, watch for fever and other warning signs, and provide emotional support. Looking after their own health and asking the team for support services is also important.
